Our study demonstrates an increase in the phosphotyrosine-dependent signaling in the SOD1G93A model of ALS and, in particular, identifies STEP as a new actor of the complex pathogenetic mechanisms of the disease. Here, PTPN5 is linked to amyotrophic lateral sclerosis.